| 1 |
34532950 | The ongoing evolution of basal insulin therapy over 100 years and its promise for the future. | 2022 Jan |
1 |
| 2 |
35141727 | The Comparative Dosing and Glycemic Control of Intermediate and Long-Acting Insulins in Adult Patients With Type 1 and 2 Diabetes Mellitus. | 2022 Feb |
1 |
| 3 |
35350098 | Insulin Allergy to Detemir Followed by Rapid Onset of Diabetic Ketoacidosis: A Case Report and Literature Review. | 2022 |
2 |
| 4 |
35579011 | Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis. | 2022 May 25 |
1 |
| 5 |
33354715 | Weight gain associated with insulin detemir vs insulin glargine in clinical practice: A retrospective longitudinal cohort study. | 2021 Feb 19 |
4 |
| 6 |
33592769 | Development and validation of a method for quantification of human insulin and its synthetic analogues in plasma and post-mortem sera by LC-MS/HRMS. | 2021 Apr 1 |
1 |
| 7 |
33721211 | All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK. | 2021 May |
9 |
| 8 |
33865836 | Detemir vs neutral protamine Hagedorn insulin for diabetes mellitus in pregnancy: a comparative effectiveness, randomized controlled trial. | 2021 Jul |
1 |
| 9 |
34330786 | Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE Study. | 2021 Sep |
1 |
| 10 |
33166419 | (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. | 2020 Nov 9 |
1 |
| 11 |
29987755 | Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study. | 2019 Mar |
4 |
| 12 |
30443804 | Successful Outcomes with Insulin Degludec in Pregnancy: A Case Series. | 2019 Feb |
1 |
| 13 |
31073850 | Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy. | 2019 May 9 |
1 |
| 14 |
31096094 | Identification of recombinant human insulin and biosynthetic insulin analogues by multiplexed targeted unlabeled mass spectrometry of proteotypic tryptic peptides. | 2019 Aug 5 |
3 |
| 15 |
31124388 | Physico-chemical stability of co-formulation of PEGylated human amylin with insulin. | 2019 Oct |
1 |
| 16 |
31416537 | A subcutaneous insulin pharmacokinetic model for insulin Detemir. | 2019 Sep |
2 |
| 17 |
29300101 | Quality-of-life and treatment satisfaction in actual clinical practice of patients with Type 1 diabetes mellitus (T1DM) and hypoglycemia treated with insulin degludec. | 2018 Jun |
1 |
| 18 |
29314667 | Clinical characteristics of type 2 diabetes patients with discordance between HbA1c and fasting plasma glucose in the real world: An analysis of the ORBIT study. | 2018 May |
1 |
| 19 |
29745913 | BENEFITS OF EARLY SCREENING AND PROPER TREATMENT IN PATIENT WITH SIGNIFICANT RISK FACTORS FOR GESTATIONAL DIABETES MELLITUS (CASE REPORT). | 2018 Apr |
1 |
| 20 |
30020461 | Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection vs. Insulin Alone in Type 2 Diabetes. | 2018 Sep 1 |
3 |
| 21 |
30181850 | Effectiveness and safety of insulin glargine versus detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis. | 2018 |
1 |
| 22 |
27819164 | Current trends in the diagnosis and management of gestational diabetes mellitus in the United States. | 2017 Nov |
1 |
| 23 |
28042719 | Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults. | 2017 Jun |
1 |
| 24 |
28394183 | Assessing the Impact of Insulin Glargine and Detemir Treatment to Serum Total IGF1 Levels in the Insulin-Naive Type 2 Diabetic Patients. | 2017 Jun |
2 |
| 25 |
28683239 | COMPARISON OF EFFICACY AND SAFETY OF GLARGINE AND DETEMIR INSULIN IN THE MANAGEMENT OF INPATIENT HYPERGLYCEMIA AND DIABETES. | 2017 Sep |
1 |
| 26 |
28970434 | Comparison of Insulin Detemir and Insulin Glargine for Hospitalized Patients on a Basal-Bolus Protocol. | 2017 Apr 23 |
1 |
| 27 |
26340704 | Body Composition and Epicardial Fat in Type 2 Diabetes Patients Following Insulin Detemir Versus Insulin Glargine Initiation. | 2016 Jan |
1 |
| 28 |
26602124 | Quantitation of Insulin Analogues in Serum Using Immunoaffinity Extraction, Liquid Chromatography, and Tandem Mass Spectrometry. | 2016 |
1 |
| 29 |
26916685 | Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial. | 2016 Feb 25 |
2 |
| 30 |
27023008 | Long-acting Insulin Analogs Effect on gh/igf Axis of Children with Type 1 Diabetes: a Randomized, Open-label, Two-period, Cross-over Trial. | 2016 May |
1 |
| 31 |
27462470 | Ten-Year Trends in the Morbidity of Diabetes Mellitus and Antidiabetic Drug Utilization in Croatia: A Study Based on Routinely Collected Data. | 2016 |
1 |
| 32 |
25374101 | Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. | 2015 |
1 |
| 33 |
25701545 | Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis. | 2015 Oct |
1 |
| 34 |
26120575 | Clinical and financial outcomes of switching insulin glargine to insulin detemir in a veteran population with type 2 diabetes. | 2015 |
1 |
| 35 |
26260082 | Bioavailability of insulin detemir and human insulin at the level of peripheral interstitial fluid in humans, assessed by open-flow microperfusion. | 2015 Dec |
1 |
| 36 |
26350101 | Insulin therapy in the elderly with type 2 diabetes. | 2015 Dec |
2 |
| 37 |
26494149 | National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients with Type 2 Diabetes: The FINE-Asia Registry. | 2015 Dec |
1 |
| 38 |
26819737 | Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus. | 2015 |
1 |
| 39 |
28702229 | Detemir plus aspart and glulisine induced lipoatrophy: 2015 literature review and report of a new case. | 2015 |
1 |
| 40 |
23841569 | Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes. | 2014 Jan |
2 |
| 41 |
24855159 | Insulin analogs-are they worth it? Yes! | 2014 Jun |
1 |
| 42 |
24855160 | Insulin analogs--is there a compelling case to use them? No! | 2014 Jun |
1 |
| 43 |
25054308 | Are insulin analogues detemir or glulisine used preferentially in overweight/obese subjects? A German multicentre analysis of 38560 type 2 diabetic patients from the DPV registry. | 2014 Nov |
2 |
| 44 |
23211128 | Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome. | 2013 Apr |
2 |
| 45 |
23337144 | Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy. | 2013 Mar-Apr |
1 |
| 46 |
23670204 | Safety and effectiveness of insulin detemir in different age-groups in the a1chieve study. | 2013 Jun |
1 |
| 47 |
23710808 | [The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents: the Chinese cohort from SOLVE(TM) observational study]. | 2013 Jan |
1 |
| 48 |
23997930 | Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin? | 2013 Aug |
1 |
| 49 |
24016754 | [Clinical experiences with basal analogue insulin in routine care. Retrospective follow up analysis of a database from daily routine care]. | 2013 Sep 15 |
2 |
| 50 |
24098877 | Problem based review: the patient who has taken an overdose of long-acting insulin analogue. | 2013 |
1 |